Industry Roundtable
Share |


The Industry Roundtable brings together researchers from academic medical health centers, industry partners, and advocacy organizations to discuss and advance non-proprietary issues relating to drug and device development, evaluative and comparative effectiveness research, and the dissemination of knowledge about clinical research findings.


The purpose is to provide a forum to collaboratively identify, clarify and solve common challenges related to clinical research, as well as to foster a broader, consistent relationship and understanding where academia and industry interface.


2017 Industry Roundtable

Date:           Monday, September 25, 2017 
Location:    American College of Cardiology Conference Center
                    2400 N St NW, Washington, DC 20037
Time:          1pm – 5pm (Box lunch available at 12pm) 


Members: Registration Fee for CR Forum Members: $0
Registration Fee for non-CR Forum Members: $500.00 




12pm:                        Registration Opens

12pm – 1pm:             Networking/Box Lunch 

1pm – 3:15pm:          21st Century Cures Act – What’s Next?

3:15pm – 3:30pm:     Break/Networking

3:30pm – 5:00pm:     Future Challenges for Industry-Funded Research

1pm - 3:15pm:
Panel: 21st Century Cures Act: What's Next? 

Congress passed the 21st Century Cures Act to accelerate the rate at which scientific breakthroughs are translated into treatments, therapies, and products that improve patient care. Now that the bill has been enacted, learn what’s happening with implementation and the Administration’s plans to further bolster clinical and translational research. 

Confirmed Speakers: 

  • Joni L. Rutter, Ph.D, Director of Scientific Programs for the All of Us Research Program; See her bio here
  • Joe Selby, MD, MPH; Executive Director, Patient-Centered Outcomes Research Institute (PCORI);  See bio here
  • Lawrence A. Tabak, DDS, PhD, Principal Deputy Director, National Institutes of Health (NIH); See bio here
  • ShaAvhrée Buckman-Garner, M.D., Ph.D., FAAP, Director, Office of Translational Sciences (FDA); See bio here

3:30pm - 5:00pm
Panel: Future Challenges for Industry-Funded Research

The federal government has indicated an interest in improving public/private partnerships as well as increasing the role of user fees in regulatory review. Hear from leading members of industry about what’s next in terms of future collaboration and partnerships critical to research projects and opportunities.

Confirmed Speakers: 

  • Frank Weichold, MD, PhD; Director, Critical Path and Regulatory Science Initiatives, Office of Regulatory Science & Innovation (ORSI), FDA; See bio here
  • Andrew Dahlem, DVM, PhD; Vice President and Chief Operating Officer, Lilly Research Laboratories; See bio here


Hotel Accommodations

The Clinical Research Forum has arranged a room block at the St. Gregory Hotel, a boutique hotel in the Dupont Circle neighborhood, within an easy walking distance to the meeting location. The room block is available for Sunday, September 24, and the rate is $179 plus tax. The hotel deadline is September 1, 2017. 

Link to hotel reservations
Use IATA code: CRFM

Contact phone: 202-530-3600


Meeting Chairs

Anantha Shekhar, MD, PhD
Associate Vice President for University Clinical Affairs; Indiana University
Executive Vice President of Academic Affairs for Clinical Research; Indiana University Health
Executive Associate Dean for Research Affairs;
Director, Indiana Clinical and Translational Sciences Institute;
August M. Watanabe Professor of Medical Research;
Professor of Psychiatry, Neurobiology and Pharmacology & Toxicology, IUSM

Scott Steele, PhD
Director of Regulatory Science Programs
Director of Government and Academic Research Alliances at the University of Rochester
Associate Professor, Public Health Sciences
University of Rochester Medical Center


Interested in receiving information about the Industry Roundtable? Sign up for our mailing list. 


Sign Up Now